Replies to post #11392 on Intellect Neurosciences Inc. (fka ILNS)

[qotsa55]

mkaiz..that was an old article from before the phase 3 trials came out for both Bapi and Solanezumab. They both failed to reach their endpoints. However, I believe Bapi might still have a chance at being studied for treatment in the earliest stages of Alzheimer's. Solanezumab I believe received 100 million dollar grant and is back in phase 3 studies already. I believe the results for those phase 3 trials are due in 2018